Diclofenac Potassium Suppository

This product is a non-steroidal anti-inflammatory drug with a fast onset of action. It may produce analgesic, anti-inflammatory and antipyretic effects mainly by inhibiting the synthesis of prostaglandins. This product has no obvious accumulation effect.

Chemical name: Potassium 2-[(2,6-dichlorophenyl)amino]-phenylacetate Molecular weight: C14H10Cl2NKO2

This product is a milky white suppository made of a fatty matrix.

For rheumatoid arthritis and postoperative analgesia, anti-inflammatory and antipyretic

Children: For children over 2 years old, the dosage is 0.5-2 mg per kg body weight per day, divided into 2-3 times, depending on the severity of the disease. For the treatment of juvenile rheumatoid arthritis, the dosage can be increased to a maximum of 3 mg per kg body weight per day, divided into 2-3 times. Or follow the doctor's advice. Adults: The recommended starting dose is 100-150 mg per day. When the disease is mild or long-term treatment is required, 75-100 mg per day can be given. The total daily dose should be divided into 2-3 times.

1. Occasionally, there is upper abdominal pain, nausea, vomiting, diarrhea, abdominal cramps, indigestion, abdominal bloating, and anorexia. Rarely, there is gastrointestinal bleeding, hematemesis, melena, gastrointestinal ulcer, perforation, and bloody diarrhea. 2. Occasionally, there is headache, dizziness, and vertigo. Rarely, there is sleepiness. 3. Occasionally, there is rash. Rarely, there is urticaria. 4. Occasionally, there is an increase in serum transaminase GOT and SGPT, and rarely, there is hepatitis. 5. Rarely, there is an allergic reaction, such as asthma. 6. Rarely, there is edema. 7. Occasionally, there is mild mucosal irritation.

1. Patients with peptic ulcers are prohibited from using this product. 2. Patients who are allergic to this product and other non-steroidal anti-inflammatory drugs are prohibited from using this product. 3. Patients with a history of asthma, urticaria or allergic rhinitis caused by taking acetylsalicylic acid or other prostaglandin synthase inhibitors are prohibited from using this product. 4. Patients with severe liver and kidney dysfunction are prohibited from using this product. 5. Patients with severe blood system diseases are prohibited from using this product. 6. Patients with proctitis are prohibited from using this product.

Precautions for children: See Dosage and Administration. Precautions for pregnancy and lactation: Precautions for pregnant women, use with caution for lactating women. Precautions for the elderly: The dosage of this product should be reduced for the elderly, the weak, and those with low body weight.

1. When used in combination with potassium preparations and digoxin drugs, the plasma concentration of diclofenac may increase. 2. Various non-steroidal anti-inflammatory drugs tend to inhibit the activity of diuretics. When combined with potassium-containing diuretics, the serum K+ level may increase, so the K+ level should be monitored during this treatment. 3. The incidence of side effects may increase when used in combination with different non-steroidal anti-inflammatory drugs or glucocorticoids. 4. Although clinical study results have not shown any interaction between diclofenac and anticoagulants, individual reports indicate that there is a risk of bleeding when diclofenac is used in combination with anticoagulants. Patients should be strictly examined during the above treatment. Like other non-steroidal anti-inflammatory drugs, diclofenac may cause a short-term (temporary) inhibition of blood counts when used in high doses (200 mg).

Keep tightly closed in a cool place.

50mg

36 months

Kunshan Peili Pharmaceutical Co., Ltd.

• Founded in:

  1995-03-02

• Address:

  No. 27, Lufeng West Road, Lujia Town, Kunshan City, Jiangsu Province

• Tax NO.:

  91320583608279361D

• Registered Funds:

  $3.3 million

• Website:

  Log in to view

• Email:

  Log in to view